Canada· CA-DIN-02487993
METHYLENE BLUE INJECTION
A methylthioninium chloride product containing methylene blue, registered in Canada by PHEBRA PTY LTD. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Methylthioninium chloride is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AB17 (methylthioninium chloride), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Methylthioninium chloride · ATC V03AB17
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- METHYLENE BLUE
- Manufacturer
- PHEBRA PTY LTD
- Country
- Canada (CA)
- ATC code
- V03AB17
- ATC class
- Methylthioninium chloride
- Defined daily dose
- 0.105 g, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
213 interactions on record for methylthioninium chloride.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylthioninium chloride · interactions on record
213 records
- 141 severe
- 71 moderate
- 1 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylthioninium chloride in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesArthcal 1% METHYLENE BLUEBeijing JUNGE Technology Co., Ltd.
- United KingdomMethylthioninium chloride (methylene blue) 100mg/10ml solution for injection ampoulesMartindale Pharmaceuticals Ltd
- BelgiumLumeblue 25 mgCosmo Technologies
- CzechiaMETHYLTHIONINIUMCHLORID PROVEBLUEPROVEPHARM SAS, Marseille
- IrelandLumeblue 25 mg prolonged-release tabletsAlfasigma S.p.A
- FinlandLumeblueCosmo Technologies Limited
- SwedenMethylthioninium chloride Proveblue 5 mg/ml Injektionsvätska, lösningProvepharm SAS
- NorwayMetibloSterop
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Metiblo
- United Kingdom (Northern Ireland) · Methylthioninium Chloride Phebra Limited
- Iceland · Proveblue
- Italy · Metiltioninio Cloruro Bioindustria L.I.M., Metiltioninio Cloruro Monico
- Liechtenstein · Proveblue
- Norway · Proveblue
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffa35281-d52f-4430-a6f0-bbb7a6235f29 GET /v1/drugs/ffa35281-d52f-4430-a6f0-bbb7a6235f29?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02487993",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V03AB17",
"schedule": [
"Ethical"
],
"drug_code": "97817",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"METHYLENE BLUE"
],
"product_categorization": null
}See everything about methylthioninium chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.